Does increasing the daily tamoxifen dose in patients with diminished CYP2D6 activity increase toxicity? von Hertz, Daniel Louis, Snavely, Anna C., Evans, James P, Ibrahim, Joseph G, Anderson, Steven M., Friedman, Kenneth J, Weck, Karen E, Rubin, Peter, Olajide, Oludamilola A., Moore, Susan G., Raab, Rachel Elizabeth, Carrizosa, Daniel R., Corso, Steven William, Schwartz, Garry, Peppercorn, Jeffrey M., Graham, Mark, Canale, Sean Thomas, McLeod, Howard L., Carey, Lisa A., Irvin, William Johnson

Volltext